✦ LIBER ✦

Coherin™ peptides induce clinical response and remission in patients with active Crohn’s disease

✍ Scribed by Gary R Lichtenstein; Henry I Jacoby

Book ID: 119393454
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 37 KB
Volume: 97
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(02)05246-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coherin™ peptides induce clinical respon

Coherin™ peptides induce clinical response and remission in patients with ulcerative colitis

✍ Gary R Lichtenstein; Henry I Jacoby 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB

Coherin™ peptides effectively maintain r

Coherin™ peptides effectively maintain remission in patients with Crohn’s disease for 2 years

✍ Gary R Lichtenstein; Henry I Jacoby 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB

Microinflammation in patients with Crohn

Microinflammation in patients with Crohn's disease in clinical remission

✍ Nitsan Maharshak; Liaz Zilberman; Yaron Arbel; Itzhak Shapira; Shlomo Berliner; 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 180 KB

Muscle performance in patients with Croh

Muscle performance in patients with Crohn's disease in clinical remission

✍ Jean-Baptiste Wiroth; Jérôme Filippi; Stéphane M Schneider; Rima Al-Jaouni; Nico 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

CDP870, a humanized anti-TNF antibody fr

CDP870, a humanized anti-TNF antibody fragment, induces clinical response with remission in patients with active Crohn's disease (CD)

✍ Stefan Schreiber; Paul Rutgeerts; Richard Fedorak; Munna Khaliq-Kareemi; Kamm Mi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Sarcopenia is prevalent in patients with

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission

✍ Stéphane M. Schneider; Rima Al-Jaouni; Jerôme Filippi; Jean-Baptiste Wiroth; Gil 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

## Background: Patients with Crohn's disease (CD) are prone to osteoporosis. A loss of muscle mass, called sarcopenia, is responsible for an increased risk of disability. Many factors associated with osteopenia also decrease muscle mass. The aim of the present study was to measure the prevalence o